Exhibit 107 

 

Calculation of Filing Fee Tables

 

FORM S-8

…………..

(Form Type)

 

KIORA PHARMACEUTICALS, INC.

……………………………………………………..…

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered (1)

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Newly Registered Securities

Fees to Be Paid

Equity

Common Stock, par value $0.01 per share(2)(3)(4)

Other

5,000,000 (2)

$0.4937 (3)

$2,468,500.00

$147.60 per $1,000,000

$364.35

Total Offering Amounts

$2,468,500.00

$364.35

Total Fee Offsets

$—

Net Fee Due

$364.35

 

			(1)			Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (the “Registration Statement”) shall also cover any additional shares of the common stock, $0.01 par value per share (the “Common Stock”), of Kiora Pharmaceuticals, Inc. (the “Registrant”) that become issuable with respect to the securities identified in the above table, by reason of any stock dividend, stock splits, reverse stock splits, recapitalizations, reclassifications, mergers, split-ups, reorganizations, consolidations and other capital adjustments effected without receipt of consideration that increases the number of outstanding shares of Common Stock.

			(2)			Represents 5,000,000 shares of Common Stock available for issuance under the Registrant’s 2024 Equity Incentive Plan (the “2024 Plan”) pursuant to stockholder approval obtained on May 1, 2024.

			(3)			Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act on the basis of $0.4937, the average of the high and low prices of a share of Common Stock as reported on The Nasdaq Stock Market LLC on May 9, 2024.